Clinical Trials

What Is A Trial?

A clinical trial tests new treatments before they are available to patients through the mainstream market.  These new treatments are tested extensively, first in the laboratory and then in a series of studies called phase I, II and III clinical trials. These studies are done under very controlled conditions in order to determine if promising approaches to disease prevention, diagnosis, and treatment are safe and effective.

Types Of Clinical Trials

  • Treatment trials test new treatments (like a new drug, new approaches to surgery or radiation therapy, new combinations of treatments, or new methods such as gene therapy).
  • Prevention trials test new approaches, such as medicines, vitamins, minerals, or other supplements that doctors believe may lower the risk of disease.
  • Screening trials test the best way to find a disease such as cancer, especially in its early stages.

How Can I Be Referred?

By combining the genitourinary research programs at the Vancouver Prostate Centre and the BC Cancer Agency, clinical trial patients can participate in a full range of investigational studies. Patients interested in participating should contact their doctor for referral.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.